Cargando…
COVID-19, Pre-Eclampsia, and Complement System
COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with thrombotic events. Complement system (C) via its cross-talk with the contact and coagulation systems contributes si...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635918/ https://www.ncbi.nlm.nih.gov/pubmed/34868042 http://dx.doi.org/10.3389/fimmu.2021.775168 |
_version_ | 1784608423347748864 |
---|---|
author | Agostinis, Chiara Mangogna, Alessandro Balduit, Andrea Aghamajidi, Azin Ricci, Giuseppe Kishore, Uday Bulla, Roberta |
author_facet | Agostinis, Chiara Mangogna, Alessandro Balduit, Andrea Aghamajidi, Azin Ricci, Giuseppe Kishore, Uday Bulla, Roberta |
author_sort | Agostinis, Chiara |
collection | PubMed |
description | COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with thrombotic events. Complement system (C) via its cross-talk with the contact and coagulation systems contributes significantly to the severity and pathological consequences due to SARS-CoV-2 infection. These immunopathological mechanisms overlap in COVID-19 and pre-eclampsia (PE). Thus, mothers contracting SARS-CoV-2 infection during pregnancy are more vulnerable to developing PE. SARS-CoV-2 infection of ECs, via its receptor ACE2 and co-receptor TMPRSS2, can provoke endothelial dysfunction and disruption of vascular integrity, causing hyperinflammation and hypercoagulability. This is aggravated by bradykinin increase due to inhibition of ACE2 activity by the virus. C is important for the progression of normal pregnancy, and its dysregulation can impact in the form of PE-like syndrome as a consequence of SARS-CoV-2 infection. Thus, there is also an overlap between treatment regimens of COVID-19 and PE. C inhibitors, especially those targeting C3 or MASP-2, are exciting options for treating COVID-19 and consequent PE. In this review, we examine the role of C, contact and coagulation systems as well as endothelial hyperactivation with respect to SARS-CoV-2 infection during pregnancy and likely development of PE. |
format | Online Article Text |
id | pubmed-8635918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86359182021-12-02 COVID-19, Pre-Eclampsia, and Complement System Agostinis, Chiara Mangogna, Alessandro Balduit, Andrea Aghamajidi, Azin Ricci, Giuseppe Kishore, Uday Bulla, Roberta Front Immunol Immunology COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with thrombotic events. Complement system (C) via its cross-talk with the contact and coagulation systems contributes significantly to the severity and pathological consequences due to SARS-CoV-2 infection. These immunopathological mechanisms overlap in COVID-19 and pre-eclampsia (PE). Thus, mothers contracting SARS-CoV-2 infection during pregnancy are more vulnerable to developing PE. SARS-CoV-2 infection of ECs, via its receptor ACE2 and co-receptor TMPRSS2, can provoke endothelial dysfunction and disruption of vascular integrity, causing hyperinflammation and hypercoagulability. This is aggravated by bradykinin increase due to inhibition of ACE2 activity by the virus. C is important for the progression of normal pregnancy, and its dysregulation can impact in the form of PE-like syndrome as a consequence of SARS-CoV-2 infection. Thus, there is also an overlap between treatment regimens of COVID-19 and PE. C inhibitors, especially those targeting C3 or MASP-2, are exciting options for treating COVID-19 and consequent PE. In this review, we examine the role of C, contact and coagulation systems as well as endothelial hyperactivation with respect to SARS-CoV-2 infection during pregnancy and likely development of PE. Frontiers Media S.A. 2021-11-17 /pmc/articles/PMC8635918/ /pubmed/34868042 http://dx.doi.org/10.3389/fimmu.2021.775168 Text en Copyright © 2021 Agostinis, Mangogna, Balduit, Aghamajidi, Ricci, Kishore and Bulla https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Agostinis, Chiara Mangogna, Alessandro Balduit, Andrea Aghamajidi, Azin Ricci, Giuseppe Kishore, Uday Bulla, Roberta COVID-19, Pre-Eclampsia, and Complement System |
title | COVID-19, Pre-Eclampsia, and Complement System |
title_full | COVID-19, Pre-Eclampsia, and Complement System |
title_fullStr | COVID-19, Pre-Eclampsia, and Complement System |
title_full_unstemmed | COVID-19, Pre-Eclampsia, and Complement System |
title_short | COVID-19, Pre-Eclampsia, and Complement System |
title_sort | covid-19, pre-eclampsia, and complement system |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635918/ https://www.ncbi.nlm.nih.gov/pubmed/34868042 http://dx.doi.org/10.3389/fimmu.2021.775168 |
work_keys_str_mv | AT agostinischiara covid19preeclampsiaandcomplementsystem AT mangognaalessandro covid19preeclampsiaandcomplementsystem AT balduitandrea covid19preeclampsiaandcomplementsystem AT aghamajidiazin covid19preeclampsiaandcomplementsystem AT riccigiuseppe covid19preeclampsiaandcomplementsystem AT kishoreuday covid19preeclampsiaandcomplementsystem AT bullaroberta covid19preeclampsiaandcomplementsystem |